Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Is A Clozapine REMS Still Needed? Two US FDA Adcomms Will Weigh Neutropenia Risk Mitigation
Nov 15 2024
•
By
Sue Sutter
The Clozapine REMS is intended to mitigate the risk of severe neutropenia.
(Shutterstock)
More from US Advisory Committees
More from Product Reviews